Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
Andonopoulos
A P
AP
Meimaris
N
N
Daoussis
D
D
Bounas
A
A
Yiannopoulos
G
G
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis* / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D015415:Biomarkers / Q000032:analysis; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D008297:Male; D011379:Prognosis; D012720:Severity of Illness Index; D017211:Treatment Failure; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000305:Adrenal Cortex Hormones; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015415:Biomarkers; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab